Shanghai BioGerm Medical Technology Co., Ltd. was established in March 2017. It is committed to the research and development and application of molecular diagnostic reagents for infectious pathogens. It is deeply involved in the development of multiple fluorescent PCR diagnostic reagents, pathogen first-generation sequencing and trace virus second-generation sequencing reagents and related technologies. service. The company is committed to solving the problem of difficult diagnosis caused by genetic mutations of infectious pathogens. It has achieved the goal of making molecular ....